Oncology Hematology Care - Kenwood — Cincinnati, Ohio

Oncology Hematology Care - Kenwood is a clinical research site located in Cincinnati, Ohio, United States 45236.

Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.

Oncology Hematology Care - Kenwood has participated in 188 clinical trials with 117 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cincinnati

Browse all research sites in Ohio · View every site in Cincinnati

Sponsor Feasibility Report

Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Hematology Care - Kenwood?

Oncology Hematology Care - Kenwood has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Hematology Care - Kenwood conducted?

Oncology Hematology Care - Kenwood has 188 clinical trials on record, with 117 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Oncology Hematology Care - Kenwood accredited by Crixeo Clinical Trials?

Oncology Hematology Care - Kenwood has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology Hematology Care - Kenwood?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.